863 Pill - white capsule/oblong, 18mm
Pill with imprint 863 is White, Capsule/Oblong and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 863
Topiramate Extended-Release
- Imprint
- 863
- Strength
- 25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0863
- Inactive Ingredients
-
alcohol,
ammonia,
butyl alcohol,
microcrystalline cellulose,
ethylcellulose,
ferrosoferric oxide,
gelatin,
hydrogenated castor oil,
hypromelloses,
isopropyl alcohol,
polyethylene glycol,
potassium hydroxide,
povidone,
propylene glycol,
shellac,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triethyl citrate,
water
Note: Inactive ingredients may vary.
Related images for "863"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,337)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.